What We're Reading: VA Nominee and Retirement Choice; Mega Deals and PCPs; Novartis Buys Gene Therapy Firm
Ronny L. Jackson, MD, would give up $1 million in retirement income to head the Department of Veterans Affairs and work in the Trump administration; mega healthcare deals endanger independent practices of primary care providers; Novartis is buying a gene therapy firm focused on spinal muscular atrophy.
Jackson Would Give Up $1 Million in Retirement Income to Head the VA, Work for Trump Administration
The nomination of President Donald Trump’s doctor, Ronny L. Jackson, MD, to head the Department of Veterans Affairs has grown more complicated by the Navy physician’s pending military promotion,
Mega Deals Endanger Independent Primary Care Providers
New mega-mergers as well as an increasing propensity for patients to head to urgent care centers or retail clinics is putting pressure on independent primary care doctors,
Novartis Buying Gene Terapy Firm Focused on Spinal Muscular Atrophy
Novartis is buying gene therapy company AveXis for $8.7 billion,
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Related Articles
- Around the Helix: Cell and Gene Therapy Company Updates – September 17, 2025
September 17th 2025
- ImmunoLogic, Episode 6: "The Future of Personalized Cancer Vaccines”
September 15th 2025
- Top News in Lymphoma Cell Therapy for World Lymphoma Awareness Day 2025
September 15th 2025
- Duchenne Action Month 2025: Looking Back at News and Expert Insights
September 14th 2025